A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation

Despite differences in model designs and structures, it was mostly possible to replicate the results published by different authors and identify variables responsible for differences between ICERs using a reference model approach. This enables a better interpretation of published findings by focusing attention on the assumptions underlying the key model features accounting for differences. </AbstractSection> Copyright The Author(s) 2013

MoreLess

Year of publication:	2013
Authors:	Sorensen, Sonja ; Peng, Siyang ; Monz, Brigitta ; Bradley-Kennedy, Carole ; Kansal, Anuraag
Published in:	PharmacoEconomics. - Springer, ISSN 1170-7690. - Vol. 31.2013, 7, p. 589-604
Publisher:	Springer

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10011001718